MAY 16·The Motley FoolMed
Kestra Medical Grew Revenue 63%. One Fund Still Trimmed 351,000 Shares
Omega Fund Management trimmed its stake in Kestra Medical Technologies (KMTS) by selling 351,442 shares, valued at an estimated $8.28 million, despite the company's strong revenue growth of 63%. Kestra Medical focuses on advanced wearable cardiac devices and digital health solutions, reporting $24.6 million in revenue for the third quarter and raising full-year guidance. Omega Fund Management still maintains a significant 12.5% holding in KMTS, indicating potential long-term confidence in the company's growth trajectory despite its current investment phase and widening net loss.